Time for New Guidance on Fertility Treatment in Women With M

Contrary to previous research, a new study suggests fertility treatments pose little risk of MS relapse in women who undergo fertility treatments, suggesting it may be time for new clinical guidance.

Related Keywords

University Of Pennsylvania , Pennsylvania , United States , Illinois , Northwestern University , Chicago , Philadelphia , Roche Genentech , Julie Fiol , Rachel Brandstadter , Edithl Graham , Neuroimmunology Neuroinflammation , Roche Ltd , Northwestern Neurology Department , Corporal Michaelj Crescenz Va Medical Center , Perelman School Of Medicine , Novartis , Tavistock Life Sciences , National Ms Society , Medscape Medical , Medscape Medical News , Perelman School , Corporal Michaelj Crescenz , Multiple Sclerosis Ms , Multiple Sclerosis , Us , Multiple Sclerosis Progression , Als Progression , Fertility , Primary Progressive Multiple Sclerosis , Pms , Relapsing Remitting Multiple Sclerosis , Arms , Ultiple Sclerosis Relapsing Remitting , Ob Gyn And Womens Health Nursing , Disease Modifying Therapy , Mt , Multiple Sclerosis Relapse , S Relapse , Elapse Of Multiple Sclerosis , Elapse Of Ms , Pregnancy , Fem ,